CORCEPT THERAPEUTICS INCORPORATED

Public Equity (NASDAQ)BiotechnologyPublic CompanyPharmaceuticals

📍 Redwood City, California, United States• Founded 1998

StreetZero Signal 55

Be the first to signal interest

About CORCEPT THERAPEUTICS INCORPORATED

Corcept Therapeutics Incorporated is a public biotechnology company founded in 1998 and headquartered in Redwood City, California. It develops medications for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders. The company is listed on NASDAQ under ticker CORT and maintains a website at www.corcept.com.

LATEST FUNDINGRule 144

$113K

Announced 2026-11-10

TOTAL RAISED$190.59M

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for CORCEPT THERAPEUTICS INCORPORATED.

Create free account Sign in

Free plan includes 3 full deal profiles every month.

IN THE NEWS

EMPLOYEES—

FOUNDED1998

HQRedwood City, California, United States

Industry

Public Equity (NASDAQ)

Investors

Alta Partners Sutter Hill Ventures Longitude Capital Paperboy Ventures Cambridge Investment Research Stanford University

Key highlights

Operates as a NASDAQ-listed public company focused on severe disorder treatments.
Has raised 190.59M USD across 13 rounds with notable venture backers.
Announced a $200 million stock repurchase program funded by cash and investments.
Maintains a debt-free balance sheet with growing analyst interest in its valuation.